CPRC
DXCM icon

Consolidated Portfolio Review Corp’s DexCom DXCM Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,818
Closed -$246K – 462
2025
Q2 		$246K Buy
+2,818
New +$221K 0.03% 390
2025
Q1 		– Sell
-2,824
Closed -$220K – 383
2024
Q4 		$220K Buy
+2,824
New +$209K 0.03% 341
2024
Q3 		– Sell
-2,824
Closed -$320K – 315
2024
Q2 		$320K Buy
2,824
+11
+0.4% +$1.39K 0.07% 228
2024
Q1 		$390K Buy
2,813
+205
+8% +$25.8K 0.1% 180
2023
Q4 		$324K Sell
2,608
-29
-1% -$2.96K 0.07% 222
2023
Q3 		$246K Buy
2,637
+29
+1% +$3.27K 0.06% 269
2023
Q2 		$335K Hold
2,608
– – 0.08% 216
2023
Q1 		$303K Buy
+2,608
New +$292K 0.08% 208

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return